We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Renal Cell Carcinoma

Journal Scan / Research · April 01, 2021

Real-World Outcomes in Patients With mRCC According to Risk Factors

Future Oncology (London, England)


Additional Info

Future Oncology (London, England)
Real-World Outcomes in Patients With Metastatic Renal Cell Carcinoma According to Risk Factors: The STAR-TOR Registry
Future Oncol 2021 Mar 16;[EPub Ahead of Print], A Strauss, M Schmid, M Rink, M Moran, S Bernhardt, M Hubbe, L Bergmann, K Schlack, M Boegemann

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading